MedPath

NOVO-MEFENAMIC CAPSULES 250MG

NOVO-MEFENAMIC CAPSULES 250MG

Discontinued
DIN Number

02239836

Drug Class

Human

Market Date

N/A

Company
HC

novopharm limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02239836
AIG Number0102336001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AG01 MEFENAMIC ACID
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

MEFENAMIC ACIDActive
Strength: 250 MG
Monograph: MEFENAMIC ACID

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.